Skip to main content
SpringerLink
Log in
Book cover

Immunoendocrinology: Scientific and Clinical Aspects pp 343–367Cite as

Insulin Autoimmune Syndrome (Hirata Disease)

  • Chapter
  • First Online:

Part of the book series: Contemporary Endocrinology ((COE))

Summary

The insulin autoimmune syndrome (IAS), or Hirata’s disease, is characterized by the combination of fasting hypoglycemia, high concentration of total immunoreactive insulin, and presence of autoantibodies to native human insulin in serum. Since Hirata et al. first described the disease in 1970, there have been 330 reported cases of IAS during the past 37 years in Japan. IAS is the third leading cause of spontaneous hypoglycemia in Japan while only 47 cases in Caucasians and 20 cases in East Asians excluding Japanese have been reported in the past 37 years. Insulin autoantibodies production is classified as monoclonal or polyclonal, with the majority of IAS cases classified as polyclonal. A striking association between human leukocyte antigen (HLA) class II alleles DRB1*0406/DQA1*0301/DQB1*0302 and Japanese IAS cases with polyclonal insulin autoantibodies, which we found in 1992, has been well confirmed. Glutamate at position 74 in the HLA-DR4β1-chain was shown to be essential to the production of polyclonal insulin autoantibodies in IAS, whereas alanine at the same position of the HLA-DRβ1-chain might be important in the production of monoclonal insulin autoantibodies. Another interesting finding is an exposure of reducing compounds with SH group ahead of development of IAS. After reducing human insulin, T-cell recognized fragmented human insulin molecule in the context of DRB1*0406 molecules. Although methimazole was a representative reducing compound for the development of IAS before 2003, an increasing number of alfa lipoic acid-induced IAS has been recently remarkable.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   249.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  1. Schlosstein L, Terasaki PI, Bluestone R, et al. High association of an HL-A antigen B27 with ankylosing spondylitis. N Engl J Med 1973;288:704–706.

    Article  PubMed  CAS  Google Scholar 

  2. Park MS, Terasaki PI, Ahmed AR, et al. HLA-DRw4 in 91% of Jewish pempemphigus vulgaris patients. Lancet 1979;2:441–443.

    Article  PubMed  CAS  Google Scholar 

  3. Juji T, Satake M, Honda Y, et al. HLA antigens in Japanese patients with narcolepsy. Tissue Antigens 1984;24:316–319.

    Article  PubMed  CAS  Google Scholar 

  4. Prochazka EJ, Terasaki PI, Park MS, et al. Association of primary sclerosing cholangitis with HLA-DRw52a. N Engl J Med 1990;322:1842–1844.

    Article  PubMed  CAS  Google Scholar 

  5. Hirata Y, Ishizu H, Ouchi N, et al. Insulin autoimmunity in a case of spontaneous hypoglycemia. J Japan Diab Soc 1970;13:312–320.

    Google Scholar 

  6. Hirata Y, Arimichi M. Insulin autoimmune syndrome – the second case. J Japan Diabetes Soc 1972;15:187–192.

    Google Scholar 

  7. Folling J, Norman N. Hyperglycemia, hypoglycemic attacks and production of anti-insulin autoantibodies without previous known immunization. Immunological and functional studies in a patient. Diabetes 1972;21:814–826.

    PubMed  CAS  Google Scholar 

  8. Hirata Y, Tominaga M, Ito J, et al. Spontaneous hypoglycemia with insulin autoimmunity in Graves’ disease. Ann Intern Med 1974;81:214–218.

    PubMed  CAS  Google Scholar 

  9. Oneda A, Matsuda K, Sato M, et al. Hypoglycemia due to apparent autoantibodies to insulin. Characterization of insulin-binding protein. Diabetes 1974;23:41–50.

    PubMed  CAS  Google Scholar 

  10. Uchigata Y, Kuwata S, Tokunaga K, et al. Strong association of insulin autoimmune syndrome with HLA-DR4. Lancet 1992;339:393–394.

    Article  PubMed  CAS  Google Scholar 

  11. Uchigata Y, Eguchi Y, Takayama-Hasumi S, et al. Insulin autoimmune syndrome (Hirata disease): clinical features and epidemiology in Japan. Diabetes Res Clin Pract 1994;22:89–94.

    Article  PubMed  CAS  Google Scholar 

  12. Takayama-Hasumi S, Eguchi Y, Sato A, et al. Insulin autoimmune syndrome is the third leading cause of spontaneous hypoglycemic attacks in Japan. Diabetes Res Clin Pract 1990;10:211–214.

    Article  PubMed  CAS  Google Scholar 

  13. Hirata Y. Methimazole and insulin autoimmune syndrome with hypoglycemia. Lancet 1983;2:1037–1038.

    Article  PubMed  CAS  Google Scholar 

  14. Uchigata Y, Hirata Y, Omori Y. A nobel concept of type VII hypersensitivity induced by insulin autoimmune syndrome (Hirata’s disease). Autoimmunity 1995;20:207–208.

    Article  PubMed  CAS  Google Scholar 

  15. Uchigata Y, Hirata Y, Iwamoto Y. Drug-induced insulin autoimmune syndrome. Diabetes Res Clin Pract 2009;89:e19–e20.

    Article  Google Scholar 

  16. Wasada T, Eguchi Y, Takayama-Hasumi S, et al. Reverse phase high performance liquid chromatographic analysis of circulating insulin in the insulin autoimmune syndrome. J Clin Endocrinol Metab 1988;66:153–158.

    Article  PubMed  CAS  Google Scholar 

  17. Eguchi Y, Uchigata Y, Yao K, et al. Longitudinal changes of serum insulin concentration and insulin antibody features in persistent insulin autoimmune syndrome (Hirata’s disease). Autoimmunity 1994;19:279–284.

    Article  PubMed  CAS  Google Scholar 

  18. Uchigata Y, Yao K, Takayama-Hasumi S, et al. Human monoclonal IgG1 insulin autoantibody from insulin autoimmune syndrome directed at determinant at asparagine site on insulin B-chain. Diabetes 1989;38:663–666.

    Article  PubMed  CAS  Google Scholar 

  19. Uchigata Y, Takayama-Hasumi S, Kawanishi K, et al. Inducement of antibody that mimics insulin action on insulin receptor by insulin autoantibody directed at determinant at asparagine site on human insulin B chain. Diabetes 1991;40:966–970.

    Article  PubMed  CAS  Google Scholar 

  20. Uchigata Y, Eguchi Y, Takayama-Hasumi S, et al. The immunoglobulin class, the subclass and the ratio of κ:λ light chain of autoantibodies to human insulin in insulin autoimmune syndrome. Autoimmunity 1983;3:289–297.

    Article  Google Scholar 

  21. Uchigata Y, Tokunaga K, Nepom G, et al. Differential immunogenetic determinants of polyclonal insulin autoimmune syndrome (Hirata’s disease) and monoclonal insulin autoimmune syndrome. Diabetes 1995;44:1227–1232.

    Article  PubMed  CAS  Google Scholar 

  22. Schlemper RJ, Uchigata Y, Frolich M, et al. Recurrent hypoglycemia caused by the insulin autoimmune syndrome: the first Dutch case. Neth J Med 1996;48:188–192.

    Article  PubMed  CAS  Google Scholar 

  23. Uchigata Y, Omori Y, Nieda M, et al. HLA-DR4 genotype and insulin-processing in insulin autoimmune syndrome. Lancet 1992;340:1467.

    Article  PubMed  CAS  Google Scholar 

  24. Ito Y, Nieda M, Uchigata Y, et al. Recognition of human insulin in the context of HLA-DRB1*0406 products by T cells of insulin autoimmune syndrome patients and healthy donors. J Immunol 1993;15:5770–5776.

    Google Scholar 

  25. Brown JHG, Jardetzky TS, Gorga JC, et al. Three-dimensional structure of the human class II histocompatibility antigen HLA-DR1. Nature 1993;364:33–39.

    Article  PubMed  CAS  Google Scholar 

  26. Matsushita S, Takahashi K, Motoki M, et al. Allele specificity of structural requirement for peptides bound to HLA-DRB1*0405 and DRB1*0406 complexes: implication for the HLA-associated susceptibility to methimazole-induced insulin autoimmune syndrome. J Exp Med 1994;180:873–883.

    Article  PubMed  CAS  Google Scholar 

  27. Uchigata Y, Kuwata S, Tsushima T, et al. Patients with Graves’ disease who developed insulin autoimmune syndrome (Hirata disease) possess HLA-Bw62/Cw4/DR4 carrying DRB1*0406. J Clin Endocrinol Metab 1993;77:249–254.

    Article  PubMed  CAS  Google Scholar 

  28. Uchigata Y, Hirata Y, Omori Y, Iwamoto Y, Tokunaga K. Worldwide differences in incidence of insulin autoimmune syndrome (IAS, Hirata’s disease) with respect to the evolution of HLA-DR4. Hum Genet 2000;61:154–157.

    CAS  Google Scholar 

  29. Yao K, Uchigata Y, Kyono H, Yokoyama H, Eguchi Y, Fukushima H, Yamauchi K, Hirata Y. Human insulin-specific IgG antibody and hypoglycemic attacks after the injection of gold thioglucose. J Endocrinol Invest 1992;15:43–47.

    PubMed  CAS  Google Scholar 

  30. Hirata Y, Uchigata Y. Insulin autoimmune syndrome in Japan. Diabetes Res Clin Pract 1994;24(Suppl):S153–S157.

    Article  PubMed  Google Scholar 

  31. Benson EB, Ho P, Wang C, et al. Insulin autoimmunity as a cause of hypoglycemia. Arch Intern Med 1984;144:2351–2354.

    Article  PubMed  CAS  Google Scholar 

  32. Cho BY, Lee HK, Koh CS, et al. Spontaneous hypoglycemia and insulin autoantibodies in patients with Graves’ disease. Diabetes Res Clin Pract 1987;3:119–124.

    Article  PubMed  CAS  Google Scholar 

  33. Lee Y-J, Shin S-J, Torng J-K, et al. Insulin autoimmune syndrome in a methimazole-treated Graves’ disease with polyclonal anti-insulin autoantibodies. J Formos Med Assoc 1987;867:164–170.

    Google Scholar 

  34. Chen C-H, Huang M-J, Huang B-Y, et al. Insulin autoimmune syndrome as a cause of hypoglycemia – report of four cases. Chang Gung Med J 1990;13:134–142.

    CAS  Google Scholar 

  35. Lu CC, Lee JK, Yang CY, Han TM. Insulin autoimmune syndrome in a patient with methimazole and carbimazole-treated Graves’ disease: a case report. Chin Med J 1994;54(5):353–358.

    CAS  Google Scholar 

  36. Lin H-D, Chen H-D, Chang R-Y, Lin C-Y, Ching K-N. Insulin autoimmune syndrome in methimazole or carbimazole treated Chinese patients of Graves’ disease. Chin Med J 1988;42:163–168.

    CAS  Google Scholar 

  37. Wong ST, Ng WY, Thai AC. Case report: autoimmune insulin syndrome in a Chinese female with Graves’ disease. Ann Acad Med Singapore 1996;25:882–885.

    PubMed  CAS  Google Scholar 

  38. Masjhur JS. Insulin autoimmune syndrome (Hirata’s disease): severe hypoglycemic episodes in Graves’s hyperthyroidism patient treated with methimazole. Acta Med Indones 2005;37:214–216.

    PubMed  Google Scholar 

  39. Wa WY, Won JG, Tang KT, Lin HD. Severe hypoglycemic coma due to insulin autoimmune syndrome. J Chin Med Assoc 2005;68:82–86.

    Article  Google Scholar 

  40. Goldman J, Baldwin D, Rubenstein A, Klink DD. Characterization of circulating insulin and proinsulin-binding antibodies in autoimmune hypoglycemia. J Clin Invest 1979;63(5):1050–1059.

    Article  PubMed  CAS  Google Scholar 

  41. Rovira A, Valverde I, Escorihuela R, et al. Autoimmunity to insulin in a child with hypoglycemia. Acta Paediatr Scand 1982;71:343–345.

    Article  PubMed  CAS  Google Scholar 

  42. Blackshear P, Rhil D, Roner HE, et al. Reactive hypoglycemia and insulin autoantibodies in drug-induced lupus erythematosus. Ann Intern Med 1983;99:182–184.

    PubMed  CAS  Google Scholar 

  43. Sklenar I, Wilkin TJ, Diaz J-L, et al. Spontaneous hypoglycemia associated with autoimmunity specific to human insulin. Diabetes Care 1987;10:152–159.

    Article  PubMed  CAS  Google Scholar 

  44. Tenn G, Eryssenlein V, Mellinghoff HU, et al. Clinical and biochemical aspects of the insulin autoimmune syndrome (IAIS). Klin Wochenschr 1986;64:929–934.

    Article  Google Scholar 

  45. Archambeaud-Mouveroux F, Canivet B, Fressinaud C, et al. Hypoglycemie autoimmune; responsabilite du pyritinol? Presse Med 1988;17:11733–11737.

    PubMed  CAS  Google Scholar 

  46. Burch HB, Clement S, Sokol MS, et al. Reactive hypoglycemic coma due to insulin autoimmune syndrome: case report and literature review. Am J Med 1992;92:681–685.

    Article  PubMed  CAS  Google Scholar 

  47. Dozio N, Sodoyez-Goffaux F, Koch M. Are insulin autoantibodies different from exogenous insulin induced antibodies? Diabetologia 1987;30(Suppl):515A.

    Google Scholar 

  48. Anderson JH, Blackard WG, Goldman J, et al. Diabetes and hypoglycemia due to insulin antibodies. Am J Med 1978;64:8686–8873.

    Google Scholar 

  49. Benson EB, Healey LA, Barron EJ, et al. Insulin antibodies in patients receiving penicillamine. Am J Med 1985;78:857–861.

    Article  PubMed  CAS  Google Scholar 

  50. Faguer de Moustier B, Burgard M, Biotard C, et al. Syndrome hypoglycemique auto-immun iduit par le pyritinol. Diabete Metab 1988;14:423–429.

    Google Scholar 

  51. Discher T, Seipke G, Friedmann E, et al. Recurrent hypoglycemia in the insulin autoimmune syndrome. Dtsch Med Wochenschr 1990;115:1951–1955.

    Article  Google Scholar 

  52. Sluiter WJ, Marrink J, Houwen B. Monoclonal gammopathy with an insulin binding IgG(κ) M-component, associated with severe hypoglycemia. Br J Haematol 1986;62:679–687.

    Article  PubMed  CAS  Google Scholar 

  53. Scavini M, Dozio N, Sartori S, et al. Effect of treatment on insulin bioavailability and 123I insulin biodistribution in insulin immune hypoglycemia. Diabetologia 1992;35(Suppl):187A.

    Google Scholar 

  54. Meschi F, Dozio M, Bognetti E, et al. An unusual case of recurrent hypoglycemia; 10-year follow up of a child with insulin auto-immunity. Eur J Pediatr 1992;151:32–34.

    Article  PubMed  CAS  Google Scholar 

  55. Arnqvist H, Halban PA, Mathiesen UL, et al. Hypoglycemia caused by atypical insulin antibodies in a patient with benign monoclonal gammopathy. J Intern Med 1993;234:421–427.

    Article  PubMed  CAS  Google Scholar 

  56. Lidar M, Rachmani R, Half E, Ravid M. Insulin autoimmune syndrome after therapy with imipramine Diabetes Care 1999;22:524–525.

    Article  PubMed  CAS  Google Scholar 

  57. Cavaco B, Uchigata Y, Porto T, Amparo-Santos M, Sobrinho L, Leite V. Hypoglycemia due to insulin autoimmune syndrome: report of two cases with characterization of HLA alleles and insulin autoantibodies. Eur J Endocrinol 2001;145:311–316.

    Article  PubMed  CAS  Google Scholar 

  58. Herranz L, Rovira A, Grande C, Suarez A, Artinez-Ara J, Pallardo LF, Gomez-Pan A. Autoimmune insulin syndrome in a patient with progressive systemic sclerosis receiving penicillamine. Horm Res 1992;37(1–2):78–80.

    Article  PubMed  CAS  Google Scholar 

  59. Discher T, Seipke G, Freidmann E, Velcovsky HG, Federlin K. Recurrent hypoglycemia in insulin autoimmune syndrome. Dtsch Med Wochenschr 1990;115(51–52):1950–1955.

    Article  PubMed  CAS  Google Scholar 

  60. Shah P, Mares D, Fineberg E, Pescovitz M, Filo R, Jindal R, Mahoney S, Lumeng L. Insulin autoimmune syndrome as a cause of spontaneous hypoglycemia in alcoholic cirrhosis. Gastroenterology 1995;109:1673–1676.

    Article  PubMed  CAS  Google Scholar 

  61. Gregersen G, Dinesen B, Pedersen OB. Autoimmune syndrome. The first Danish case report. Ugeskr Laeger 1998;160:4539–4540.

    PubMed  CAS  Google Scholar 

  62. Casesnoves A, Mauri M, Dominguez JR, Alfayate R, Pico AM. Influence of anti-insulin antibodies on insulin immunoassays in the autoimmune insulin syndrome. Ann Clin Biochem 1998;35:768–774.

    PubMed  CAS  Google Scholar 

  63. Virally ML, Timsit L, Chanson P, Warnet A, Guillausseau PJ. Insulin autoimmune syndrome; a rare cause of hypoglycemia not to be overlooked. Diabetes Metab 1999;25:429–431.

    PubMed  CAS  Google Scholar 

  64. Konijnendijk MA, Zandbergen AA, Verhaeul FE, Baggen MG. Insulin autoimmune syndrome: the second case. Neth J Med 2001;58:18–21.

    Article  PubMed  CAS  Google Scholar 

  65. Lohman T, Kratzsch J, Kellner K, Witzigmann H, Hauss J, Paschke R. Severe hypoglycemia due to insulin autoimmune syndrome with insulin autoantibodies crossreactive to proinsulin. Exp Clin Endocrinol Diabetes 2001;109:245–248.

    Article  Google Scholar 

  66. Ruiz-Giardin JM, Cremades C, Romeo J, MArazuela M. Insulin autoimmune syndrome in a patient with viral hepatitis C. Clin Endocrinol 2002;57:411–412.

    Article  Google Scholar 

  67. Moreira RO, Lima GA, Peixoto PC, Farias ML, Vaisman M. Insulin autoimmune syndrome: case report. Sao Paulo Med J 2004;122:178–180.

    Article  PubMed  Google Scholar 

  68. Basu A, Service FJ, Yu L, Heser D, Ferries LM, Eisenbarth G. Insulin autoimmunity and hypoglycemia in seven white patients. Endocr Pract 2005;11:97–103.

    PubMed  Google Scholar 

  69. Paiva ES, Pereira AE, Lombardi MT, Nishida SK, Tachibana TT, Ferrer C, Hauache OM, Vieira JGH, Reis AF. Insulin autoimmune syndrome (Hirata disease) as differential diagnosis in patients with hyperinsulinemic hypoglycemia. Pancreas 2006;32:431–432.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Diabetes Center, Tokyo Women’s Medical University School of Medicine, Tokyo, Japan

    Yasuko Uchigata

Authors
  1. Yasuko Uchigata
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Yukimasa Hirata
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Health Sciences Center, Children's Hospital, University of Colorado, East 9th Avenue 4200, Denver, 80262, Colorado, USA

    George S. Eisenbarth

Rights and permissions

Reprints and permissions

Copyright information

© 2011 Springer Science+Business Media, LLC

About this chapter

Cite this chapter

Uchigata, Y., Hirata, Y. (2011). Insulin Autoimmune Syndrome (Hirata Disease). In: Eisenbarth, G. (eds) Immunoendocrinology: Scientific and Clinical Aspects. Contemporary Endocrinology. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-60327-478-4_21

Download citation

  • DOI: https://doi.org/10.1007/978-1-60327-478-4_21

  • Published:

  • Publisher Name: Humana Press, Totowa, NJ

  • Print ISBN: 978-1-60327-477-7

  • Online ISBN: 978-1-60327-478-4

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation